Clarity Pharmaceuticals Ltd.(AU:CU6)
A$2.05+0.39 (+23.49%)
AU:CU6
Clarity Pharmaceuticals Ltd. financials statements
A$2.05
At close:+0.39 (+23.49%)
Want to see AU:CU6 full AI Analyst Report?
Clarity Pharmaceuticals Ltd. (CU6) Income Statement
305 Followers
Clarity Pharmaceuticals Ltd. Income Statement
Last quarter (Q4 2026), Clarity Pharmaceuticals Ltd.'s total revenue was AU$0.00, a decrease of 100.00% from the same quarter last year. In Q4, Clarity Pharmaceuticals Ltd.'s net income was AU$-51.61M. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 0.00 | AU$ 9.46M | AU$ 11.51M | AU$ 9.80M | AU$ 6.46M | |
| AU$ -283.53K | AU$ 9.46M | AU$ 11.51M | AU$ 9.70M | AU$ 6.41M | |
| AU$ 118.62M | AU$ 78.56M | AU$ 56.31M | AU$ 36.06M | AU$ 29.59M | |
| Depreciation and Amortization | AU$ 283.53K | AU$ 185.08K | AU$ 153.07K | AU$ 100.51K | AU$ 46.25K |
| AU$ -118.62M | AU$ -68.91M | AU$ -44.65M | AU$ -34.20M | AU$ -30.15M | |
| AU$ -118.91M | AU$ -69.09M | AU$ -44.80M | AU$ -36.16M | AU$ -17.05M | |
| AU$ 2.10M | AU$ 5.22M | AU$ 2.77M | AU$ 1.86M | AU$ -6.69M | |
| AU$ -116.81M | AU$ -63.88M | AU$ -42.03M | AU$ -24.50M | AU$ -23.74M | |
| AU$ -107.14M | AU$ -64.30M | AU$ -42.32M | AU$ -24.60M | AU$ -23.75M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.29 | AU$ -0.20 | AU$ -0.15 | AU$ -0.09 | AU$ -0.10 |
| Diluted EPS | AU$ -0.29 | AU$ -0.20 | AU$ -0.15 | AU$ -0.09 | AU$ -0.10 |
| Weighted Average Shares Outstanding | 368.03M | 319.20M | 273.16M | 260.41M | 248.47M |
| Weighted Average Shares Outstanding (Diluted) | 368.03M | 319.20M | 273.16M | 260.41M | 248.47M |
Currency in AUD
